WASHINGTON – A weekend layoff at the Food and Drug Administration appears to have hit AI and digital medical staff particularly hard while federal regulators are following the way they monitor hospitals and insurance companies that accept the technology.
According to people interviewed by STAT, terminations with the possibility of halting or cutting back on AI regulations are causing alarms both inside and outside the agency. The use of AI in healthcare has been inflated over the past decade, with doctors adapting this technology to better detect diseases or implementing various treatment plans.
The Trump administration’s move to clean up employees with valuable AI expertise is particularly impressive given its high investment in the technology itself. Shortly after taking office, Trump announced a $500 billion investment in US-based AI infrastructure. Billionaire and leader of the US Doge services for cost savings, Elon Musk is using AI to emerge to identify government waste and redundancy. Tech companies looking for lucrative government contracts can make a profit.
This article is for stat+ subscribers only
In addition to unlocking this article, we also provide in-depth analysis, newsletters, premium events and news alerts.
Do you already have an account? Login
View all plans
To read the rest of this story, subscribe to stat+.
Subscribe
